glp-1 endurance athletes Drugs and Triathlon Performance: What Ozempic Does to What Athletes Should Know Before
Description
Learn more: UT San Antonio College of AI, Cyber and Computing | UT San Antonio Research
Introduction Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are key therapies for type 2 diabetes and obesity, regulating blood glucose by mimicking endogenous GLP-1
In todays digital age, where internet access and social media are widespread, patients are empowered to take a more proactive role in managing their healthcare
No bland food
The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric inhibitory polypeptide (GIP) dual agonist Tirzepatide for the treatment of obesity
Discover the science behind Wegovy and how GLP-1 technology helps reduce appetite, improve metabolism, and support long-term weight loss
